Accounts Receivable
Management Services
Optimize your cash flows and working
capital with Mynd Finance solutions
Optimize your cash flows and working
capital with Mynd Finance solutions
An effective and smooth Order-to-Cash cycle is crucial for companies to optimize their cash flows and collection processes. Mynd’s Accounts Receivable services facilitate companies in improving the same. Our associates work closely with business teams to effectually manage collection activities without disturbing client’s relationships. Mynd’s AR solution is comprehensive yet completely flexible, and thereby enables clients to choose the entire bouquet of services or commence a new assignment with a subset of processes, business units or locations.
Mynd’s Account Receivable offering enables organizations to focus valuable manpower and other resources on core accounting tasks rather than merely wasting time on managing collection activities. We provide service levels that exceed industry norms in several key performance indicators, including Average Invoice submission timelines, Average Invoice collection timelines & Query resolution timelines.
Our industry specific expertise in implementing best practices for optimization of the Order-to-Cash cycle help clients considerably improve their cash flows and working capital position in a short span of time.
Setting up AR follow up mechanisms
Assistance to business for sensitive customer AR
Clean-up of older AR through reconciliation
Control over DSO days through collection and reduced process gaps
Timely resolution of queries posted at Helpdesk with a Log record
Automated Configurable MISs around Collection & Defaults
Collection Watch - No AR in past due category without justifiable reasons.
Helping a beleaguered Pharma MNC facing multiple complex issues in Account receivables in terms of high DSO and Risky AR in their India operations while aggressively expanding.
Our client, an American global medical company specializing in eye care products with headquarters in Texas, USA with global revenues over 6 billions. It is a wholly owned subsidiary of a Global Pharma giant with revenue over 48 billions, headquartered out of Basel, Switzerland (Fortune 100 Company, Rank 2 in Pharmaceutical vertical). With operations in 75 countries, their products are sold in over 180 countries